October 1, 2025 · Form 4 insider transaction
Culhane Mark bought 6,411 shares of GENASYS INC at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Represents shares of common stock granted to the reporting person in lieu of accrued cash retainer for the third and fourth quarters of fiscal year 2025. The number of shares was determined based on the cash value of the accrued retainer divided by the closing price of the Company's common stock on the grant date.